Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Molecular Studies of Li-Fraumeni Syndrome and TP53-associated Disorders

NCT04367246 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT04367246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04367246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Molecular Studies of Li-Fraumeni Syndrome and TP53-associated Disorders
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Observational
Overall status
Recruiting
Start date
September 24, 2019
Completion date
September 24, 2029
Enrollment
300 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

li-fraumeni syndrome, li-fraumeni-like syndrome